These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29847892)

  • 1. The efficacy and safety of irsogladine maleate in nonsteroidal anti-inflammatory drug or aspirin-induced peptic ulcer and gastritis.
    Shim KN; Kim JI; Kim N; Kim SG; Jo YJ; Hong SJ; Shin JE; Kim GH; Park KS; Choi SC; Kwon JG; Kim JH; Kim HJ; Kim JW
    Korean J Intern Med; 2019 Sep; 34(5):1008-1021. PubMed ID: 29847892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irsogladine improves small-intestinal injuries in regular users of nonsteroidal anti-inflammatory drugs.
    Isomura Y; Yamaji Y; Yamada A; Watanabe Y; Suzuki H; Kobayashi Y; Yoshida S; Watabe H; Hirata Y; Yoshida H; Koike K
    Gastrointest Endosc; 2014 Jul; 80(1):118-25. PubMed ID: 24518124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study.
    Bianchi Porro G; Lazzaroni M; Imbesi V; Montrone F; Santagada T
    Dig Liver Dis; 2000 Apr; 32(3):201-8. PubMed ID: 10975769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Taha AS; McCloskey C; McSkimming P; McConnachie A
    Lancet Gastroenterol Hepatol; 2018 Jul; 3(7):469-476. PubMed ID: 29754836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teprenone for the prevention of low-dose aspirin-induced gastric mucosal injury in
    Chitapanarux T; Lertprasertsuke N; Kongnak A
    Scand J Gastroenterol; 2019 Oct; 54(10):1199-1204. PubMed ID: 31591940
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy: a randomized, controlled, prospective study.
    Murakami K; Okimoto T; Kodama M; Tanahashi J; Mizukami K; Shuto M; Abe H; Arita T; Fujioka T
    Scand J Gastroenterol; 2011 Mar; 46(3):287-92. PubMed ID: 21073372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irsogladine maleate suppresses indomethacin-induced elevation of proinflammatory cytokines and gastric injury in rats.
    Zhang X; Tajima K; Kageyama K; Kyoi T
    World J Gastroenterol; 2008 Aug; 14(30):4784-90. PubMed ID: 18720540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
    Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
    Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teprenone improves gastric mucosal injury and dyspeptic symptoms in long-term nonsteroidal anti-inflammatory drug users.
    Gong Y; Huang X; Chen M; Xiong L
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1344-1350. PubMed ID: 30681185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive effect of irsogladine or omeprazole on non-steroidal anti-inflammatory drug-induced esophagitis, peptic ulcers, and small intestinal lesions in humans, a prospective randomized controlled study.
    Kuramoto T; Umegaki E; Nouda S; Narabayashi K; Kojima Y; Yoda Y; Ishida K; Kawakami K; Abe Y; Takeuchi T; Inoue T; Murano M; Tokioka S; Higuchi K
    BMC Gastroenterol; 2013 May; 13():85. PubMed ID: 23672202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
    Giral A; Ozdogan O; Celikel CA; Tozun N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2004 Jul; 19(7):773-7. PubMed ID: 15209624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole.
    Graham DY; Agrawal NM; Campbell DR; Haber MM; Collis C; Lukasik NL; Huang B;
    Arch Intern Med; 2002 Jan; 162(2):169-75. PubMed ID: 11802750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group.
    Agrawal NM; Campbell DR; Safdi MA; Lukasik NL; Huang B; Haber MM
    Arch Intern Med; 2000 May; 160(10):1455-61. PubMed ID: 10826458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial: irsogladine maleate, a mucosal protective drug, accelerates gastric ulcer healing after treatment for eradication of Helicobacter pylori infection--the results of a multicentre, double-blind, randomized clinical trial (IMPACT study).
    Hiraishi H; Haruma K; Miwa H; Goto H
    Aliment Pharmacol Ther; 2010 Apr; 31(8):824-33. PubMed ID: 20132152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive effects of lansoprazole and famotidine on gastric mucosal injury induced by low-dose aspirin in Helicobacter pylori-negative healthy volunteers.
    Nishino M; Sugimoto M; Kodaira C; Yamade M; Uotani T; Shirai N; Ikuma M; Tanaka T; Sugimura H; Hishida A; Furuta T
    J Clin Pharmacol; 2011 Jul; 51(7):1079-86. PubMed ID: 20663999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs.
    Hawkey CJ; Naesdal J; Wilson I; Långström G; Swannell AJ; Peacock RA; Yeomans ND
    Gut; 2002 Sep; 51(3):336-43. PubMed ID: 12171953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irsogladine: overview of the mechanisms of mucosal protective and healing- promoting actions in the gastrointestinal tract.
    Akagi M; Amagase K; Murakami T; Takeuchi K
    Curr Pharm Des; 2013; 19(1):106-14. PubMed ID: 22950502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.